Background. The main purpose of this study was to examine histopathological changes seen in renal biopsies from patients with Wegener's granulomatosis (WG) with varying degrees of renal involvement and to study possible correlations between the morphological variables and the severity of the disease. Methods. Ninety-four patients with WG and active renal disease were included in this retrospective study. All patients had a percutaneous renal biopsy taken on their ®rst admission to the hospital and 14 patients had a second biopsy. The patients were followed for a median of 42.5 months (range 0.5±184). Results. Segmental necrotizing glomerulonephritis and extracapillary proliferation were present in 85.1 and 91.5% respectively. Of seven patients (7.4%) with normal serum creatinine and urinary protein excretion -0.5 guday, all had crescents and six had segmental glomerular necrosis. Serum creatinine at biopsy correlated signi®cantly with the percentage of glomeruli with crescents (rs0.52, Ps0.0004), with necrosis (rs0.36, Ps0.002) and with the percentage of normal glomeruli (rsÀ0.55, Ps0.0003). On a multivariate analysis, only the percentage of normal glomeruli was signi®cantly associated with renal function and development of end-stage renal disease. In 14 second biopsies after a mean of 41.2 ("26) months, chronicity scores had increased signi®cantly in 13 biopsies in spite of full immunosuppressive treatment. Conclusion. Although renal biopsy is of value in de®ning renal involvement in WG, it is of limited help in the early stage of the disease in predicting renal outcome for the individual patient. A follow-up biopsy can be useful in revealing the degree of activity and chronicity and hence be of importance for the choice of further therapy.
Introduction
Wegener's granulomatosis (WG) is a systemic disease characterized by necrotizing small-vessel vasculitis of unknown aetiology associated with granulomatous in¯ammation of the respiratory tract and of renal glomerular and interstitial disease. Patients with renal involvement generally have a worse prognosis than patients with disease localized only to the respiratory tract w1,2x, and end-stage renal disease (ESRD) will eventually develop in 11±32% w3±6x. Clinical and morphological evidence of renal involvement is found in approximately 80% of patients with WG w3,4,7x. The characteristic renal lesions are necrotizing glomerulonephritis with extracapillary proliferation. Weak glomerular immune staining may be seen in 14±18% of the patients w8,9x and this is within the spectrum of so called pauci-immune glomerulonephritis w10x. Only the infrequent occurrence in renal biopsies of interstitial necrotizing granulomatous in¯ammation is claimed to distinguish WG from renal lesions seen in other antineutrophil cytoplasmic autoantibodies (ANCA)-associated small-vessel vasculitides w11x.
The kidney biopsy is important for the subtyping of rapidly progressive glomerulonephritis, but the prognostic value of the biopsy in kidney disease associated with small-vessel vasculitides is controversial. Some reports have found pathological features such as glomerular necrosis, glomerular sclerosis, and the number of crescents to be of little help in predicting renal outcome w12,13x. Others however, have contended that renal biopsy provides valuable information when evaluating the activity of the renal vasculitis and that it is important for the therapeutic management w14±16x. There is no agreement, however, as to which renal lesions are of prognostic value, and this inconsistency makes it dif®cult to compare the results of clinical and pathological observations from different studies.
The main purpose of the present study was to examine the histopathological changes seen in percutaneous renal biopsies from patients with WG with varying degrees of renal involvement. We also wanted to look for a possible correlation between the morphological variables and the severity of the disease, and to see if these variables were of any value in predicting renal outcome.
Subjects and methods

Patients
One hundred and eight patients with WG and active renal disease who were treated in eight hospitals in Norway between 1988 and 1998 were included in this retrospective study. Each of the eight hospitals treated all patients with WG in its catchment area. The total catchment area for the hospitals comprised approximately 2.2 million inhabitants, or about 50% of the total population of Norway. All hospitals had an electronically based register for patient diagnosis, and records from these registers were used to ®nd all patients with the diagnosis of WG. The information was then scrutinized by one of the authors (KA), to con®rm the diagnosis.
Ninety-four of the 108 patients (60 males, 34 females) had a percutaneous renal biopsy taken on admission to the hospital and these patients are the basis for this report. The median age of the 94 patients was 54 years (range 11±80). Median serum creatinine concentration was 254 mmolul (range 54±1440) and 21 (22.3%) of the patients were receiving dialysis therapy at the time of biopsy. The median time from start of symptoms related to WG and biopsy was 5 months (range 0.5±214). At the time of biopsy ANCA, as determined by indirect immuno¯uorescence microscopy w17x, were positive in 78 (83.0%) of the patients (71 C-ANCA, 7 P-ANCA). Later in the course of the disease an additional nine patients became ANCA positive, so altogether 87 patients (92.6%) were ANCA positive at some point during the study. The patients were followed for a median of 42.5 months (range 0.5 to 184). Of the 89 patients who survived the acute phase of the disease (3 months after inclusion), 20 (22.5%) developed ESRD, de®ned as a need for chronic dialysis or renal transplantation.
Clinical diagnosis
The diagnosis of WG was based on the clinical criteria developed by the American College of Rheumatology w18x. As an additional requirement, patients without proven granulomatous in¯ammation in a biopsy from any tissue, had to be seropositive for ANCA. A clinical diagnosis of active renal disease was de®ned as signs of active urine sediment, i.e. more than ®ve erythrocytes per high-power ®eld (magni®cation: 3 400), or erythrocyte or granular casts. De®nitions for the terms remission and relapse are described elsewhere w5x.
Renal biopsies
The 94 biopsies were sent to and examined at the Norwegian Kidney Register. The biopsies came from a total number of 2507 renal biopsies received from the eight hospitals and 4956 from the whole of Norway during this period. The histopathological examination and the semiquantitative assessment were carried out by an experienced nephropathologist (LB) who had no prior knowledge of the clinical ®ndings or renal function. One to two cores of renal tissue were obtained and the material was ®xed in 10% buffered formalin and embedded in paraf®n. Three-micrometer-thick sections were stained with haematoxylin and eosin and periodic acid-Schiff (PAS) for light microscopy. Sections from the paraf®n embedded material were also examined by immunohistochemistry (PAP method) for deposits of IgG, IgA, IgM, C3, and C1q. The number of glomeruli with extracapillary proliferation (cellular and ®brocellular crescents) and the number of glomeruli with necrosis were expressed as percentages of the number of non-sclerotic glomeruli. The number of globally sclerotic glomeruli and the number of normal glomeruli were expressed as percentages of the total number of glomeruli in the biopsies. Crescentic glomeruli with rupture of Bowman's capsule were also noted. Interstitial oedema and signs of acute tubular damage (ATD) such as necrosis,¯attening, and shedding of the tubular epithelial cells, were recorded as dichotomous data (quÀ). Acute interstitial nephritis was de®ned as interstitial in®ltration by mononuclear anduor polymorphonuclear leukocytes, focally or diffusely. Changes characterized by in®ltrates of mononuclear leukocytes associated with tubular atrophy and interstitial ®brosis were called chronic interstitial nephritis. Subacute interstitial nephritis was a mixture of acute and chronic morphological features. The term nephron loss' was used to describe the degree of chronicity in the biopsies as a summary of the following features: the degree of interstitial ®brosis, the degree of tubular atrophy, and the fraction of globally sclerosed glomeruli. Nephron loss and interstitial ®brosis was scored on a four-point scale in the following manner: 0s0%, 1-25%, 2s25±50% and 3)50%. Vasculitis was de®ned as in®ltration of in¯am-matory cells within and around the vessel wall of arteries, arterioles, or capillaries with or without ®brinoid necrosis. The morphological minimum criteria for benign nephrosclerosis were arteriolosclerosis associated with tubulointerstitial scarring. Granulomatous in¯ammation was de®ned as an accumulation of epithelioid histocytes with or without multinucleated giant cells. The location was speci®ed as interstitial, vascular, or related to glomeruli. The term granulomatous reaction was de®ned as a destruction of the glomerulus with an accumulation of epithelioid cells anduor giant cells w19x.
Fourteen patients had a second renal biopsy taken at a later date, and these were examined and compared to the initial biopsy. The mean number of glomeruli in the 94 ®rst biopsies was 12.3, median 10 (range 4±50). The 14 rebiopsies had a mean of 14.1 glomeruli, median 13 (range 4±23).
Laboratory investigation
The patients were included in the study at the time of the ®rst kidney biopsy. Serum creatinine was used as an estimate of glomerular ®ltration rate and recorded at inclusion, at 8 weeks, and after 1 year. For patients on dialysis therapy, serum creatinine was arbitrarily set to 600 mmolul.
Treatment
At the time of biopsy a total of 29 patients (30.9%) were receiving immunomodulating therapy. Nineteen patients (20.2%) were receiving corticosteroids alone, eight patients (8.5%) were receiving corticosteroids in combination with oral or intravenous cyclophosphamide, and two patients (2.1%) were receiving corticosteroids plus azathioprine. Duration of therapy at the time of biopsy was less than 3 days for 15 (51.7%) of the 29 patients receiving treatment. Sixty-®ve patients (69.1%) were receiving no speci®c treatment for WG at the time of biopsy. Following biopsy, therapy consisted of intravenous or oral cyclophosphamide in combination with corticosteroids for 88 (93.6%) of the patients and corticosteroids and azathioprine for ®ve (5.3%). One patient died before treatment was instituted. The treatment protocol included the use of cytotoxic agents (azathioprine or cyclophosphamide) for 1 year following complete remission, after which the drugs were slowly tapered. In the event of a relapse, induction therapy with cyclophosphamide and corticosteroids was reinstituted.
Statistical analysis
Spearman's rank correlation coef®cient (r) was used to test a possible association between the percentage of normal glomeruli, glomeruli with necrosis, and glomeruli with cellular and ®brocellular crescents and serum creatinine at the time biopsy, at 8 weeks and at 1 year follow-up. A non-parametric one-way analysis of variance (ANOVA) (Kruskal±Wallis test) was employed to evaluate the association between serum creatinine and histopathological ®ndings when these were expressed on a 4-point scale. A Mann±Whitney U-test was used when the ®ndings were expressed as dichotomous values. Multiple linear regression was used to see if selected histological variables had an in¯uence on serum creatinine, and with Cox's proportional hazard model we investigated whether histological features were signi®cantly associated with the development of ESRD. Wilcoxon matched-pairs signed-rank sum test was used to make paired comparisons between morphological features when a follow-up biopsy was performed. As the Kruskal± Wallis calculations involved multiple (6) comparisons using the same outcome variable (serum creatinine), the level of signi®cance was de®ned as P-0.008 according to the Bonferroni method w20x. For the rest of the analyses the signi®cance was de®ned as P-0.05. All tests were two-tailed.
Results
Focal segmental necrotizing glomerulonephritis was present in 80 patients (85.1%) and varying degrees of extracapillary proliferation (crescents) were seen in 86 patients (91.5%). The percentage of glomeruli with crescents divided into ®ve categories is depicted in Figure 1 . Fifty-four (57.4%) of the patients had crescents in 50% or more of the glomeruli and could be classi®ed as having crescentic glomerulonephritis according to the WHO criteria w21x. In 23 (26.7%) of the patients with extracapillary proliferation all crescents were segmental, involving -50% of the circumference of Bowman's capsule (BC) and in 63 (73.3%) there were varying numbers of glomeruli with crescents involving most of the circumference of BC. Rupture of BC was observed in 65 (75.6%) of biopsies from patients with crescentic glomeruli, and in 35 (40.7%) of the patients more than 50% of the affected glomeruli had rupture of the BC. Eight (8.5%) of the 94 patients had extracapillary proliferation but no glomerular necrosis and six (6.4%) had neither glomerular necrosis nor crescents. The median serum creatinine concentration in these six patients was 114 mmolul (range 90±304) and median 24-h proteinuria was 1.7 g (range 0.7±2.9). Five of the six patients were ANCA positive. In two patients the biopsy showed vasculitis and in one biopsy there were changes consistent with an interstitial granuloma, most probably related to a vessel.
Vasculitis was demonstrated in 14 patients (14.9%). Three biopsies (3.2%) showed aggregates of epithelioid histocytes close to destroyed glomeruli, consistent with granulomatous reactions. Benign nephrosclerosis was present in 15 (16.0%) of the biopsies. All but one of the 94 biopsies (98.9%) showed some degree of interstitial or tubular involvement ( Table 1 ). The only biopsy with no visible tubulointerstitial involvement was from a 45-year-old woman with a normal serum creatinine (64 mmolul), proteinuria of 0.5 guday, and granular and erythrocyte casts seen on urine microscopy, who had received prednisolone (75 mguday) for 5 days prior to biopsy. Eleven per cent of the glomeruli in her biopsy contained cellular crescents. Table 2 depicts some biochemical and morphological patterns in seven biopsies from patients with normal serum creatinine and normal or low urinary protein excretion. All biopsies showed varying degrees of extracapillary proliferation involving 11±67% of glomeruli and all but one had glomerular necrosis.
Immunohistochemistry was performed in 93 biopsies and 26 (28.0%) had some glomerular positivity for one or more immunoglobulins or complement factors, the dominating immunoglobulin being IgM and the dominating complement factor C3 (Table 3) . Table 4 . Positive staining for immunoglobulin or complement in non-glomerular vessels was demonstrated in 10 patients (10.8%). The deposits were IgG in two patients, the rest being IgM, C3, and C1q.
There was a signi®cant positive correlation between the percentage of crescents in the biopsies and serum creatinine at the time of biopsy (rs0.52, Ps0.0004), at 8 weeks (rs0.35, Ps0.001), and at 1 year (rs0.25, Ps0.024). There was also a signi®cant correlation between the percentage of glomeruli with necrosis and initial serum creatinine (rs0.36, Ps0.002), but not serum creatinine at 8 weeks or 1 year. The percentage of normal glomeruli correlated inversely with initial serum creatinine (rsÀ0.55, Ps0.0003), serum creatinine at 8 weeks (rsÀ0.44, Ps0.0004), and at 1 year (rsÀ0.39, Ps0.001). The strongest relation between serum creatinine and the percentage of crescents and between serum creatinine and the percentage of normal glomeruli, was described by a non-linear model (exponential) R 2 being 0.304 and 0.324 respectively ( Figure 2 ). There was no signi®cant correlation between serum creatinine and the percentage of totally sclerotic glomeruli or the fraction of glomeruli with disruption of Bowman's capsule. Initial serum creatinine concentration was signi®cantly higher in patients with signs of acute tubular damage (ATD). The median value of serum creatinine at the time of biopsy was 394 mmolul (range 90±1440) for patients with ATD compared to 159 mmolul (range 64±1102) for patients without ATD (Ps0.0003). When patients with any degree of interstitial in®ltrates were grouped together, they had signi®cantly higher serum creatinine concentration at biopsy than patients without interstitial in®ltrates, median values being 304 mmolul (range 80±1440) and 99 mmolul (range 64±604) respectively (Ps0.001). One year after biopsy the difference was also signi®cant (Ps0.006). Serum creatinine did not differ between the three groups with varying Degree of interstitial ®brosis and nephron loss expressed on a four point scale; 0, 0%; 1, -25%; 2, 25±50%; 3, )50%. For de®nitions, see explanation in text (Subjects and methods, renal biopsies). degrees of interstitial in®ltrates. There was no signi®c-ant correlation between serum creatinine at any time and the degree of interstitial ®brosis or nephron loss. When a multiple linear regression model was employed using the percentage of normal glomeruli, the percentage of glomeruli with crescents, the percentage of glomeruli with necrosis, the presence of acute tubular damage and of interstitial in®ltrates as independent variables, only the fraction of normal glomeruli had an signi®cant in¯uence on serum creatinine at biopsy, at 8 weeks and after 1 year. In a Cox proportional hazard model, only the percentage of normal glomeruli were shown to have a signi®cant independent in¯uence on the development of ESRD (Ps0.012). Fourteen patients had a second renal biopsy after an average of 41.2 ("26.6) months (Table 5 ). In seven patients the indication for performing a new biopsy was signs of active vasculitis and ®ve of them had a signi®cant rise in serum creatinine immediately prior to biopsy. For seven patients, the indication was a rising or constantly high serum creatinine without signs of active vasculitis. Following the ®rst biopsy, 13 of the patients were treated with corticosteroids and cyclophosphamide and one (patient no. 4) with corticosteroids and azathioprine. Seven of the patients had at least one relapse between the two biopsies and one patient had a low-grade active (smouldering) disease. Six patients developed ESRD during the observation period. Exept in one patient (no. 3), the degree of chronicity expressed as nephron loss was signi®cantly more pronounced in the second than in the ®rst biopsy, mean ("SD) scores being 2.14 ("1.0) and 0.43 ("0.6) respectively (Ps0.001).
Discussion
In this study of renal biopsies from 94 patients with WG and active renal disease, segmental glomerular necrosis and extracapillary proliferation were present in 85.1 and 91.5% of the patients respectively, and 99% had some tubulointerstitial involvement. In earlier studies of ANCA-associated vasculitides, renal biopsies have demonstrated segmental necrosis in 98±100% and varying degrees of extracapillary proliferation in 85±94% w8,10,22x. The fraction of patients with glomerular necrosis is somewhat lower than reported in these studies, but our patients had varying degrees of clinical renal involvement, including 23% with serum creatinine -125 mmolul (results not shown). It is of interest to note, however, that glomerular necrosis and crescents were seen in seven patients without elevated serum creatinine and with no or only very scant proteinuria. All of these patients had rather extensive haematuria, suggesting that destructive in¯ammation in glomerular capillaries with bleeding into Bowman's space could be one of the early events in the development of glomerulonephritis in WG. These ®ndings indicate that morphological criteria might be a better method of de®ning renal involvement in vasculitis than renal functional measurements, and could be of importance in deciding on whether or not aggressive treatment should be initiated. In eight patients, there was crescent formation without concurrent glomerular ®brinoid necrosis. Although this could be a question of how representative the individual biopsy is as well as a question of the number of slides taken from each specimen, it seems somewhat contradictory to the commonly held view that necrosis is the earliest glomerular sign in crescentic glomerulonephritis w23,24x. The prevalence of immune deposits was higher in our study than in most earlier series of patients with ANCA-associated vasculitis w8,10,22x, but in a recent report from the European multicentre trials (EUVAS) the prevalence compared well with ours w25x. Except in two patients with diffuse granular deposits of IgA, the staining was of low intensity and focally distributed. It was predominantly IgM, C3, and C1q and thought to be a consequence of passive trapping in the mesangium. There are several studies describing the coexistence of IgA and P-ANCA in rapidly progressive glomerulonephritis w26±28x, and in one study two out of 100 patients with IgA nephropathy had high titres of IgG anti-myeloperoxidase antibodies in their serum w29x. To our knowledge there have been no prior reports of IgA immune deposits in patients with C-ANCA-positive crescentic glomerulonephritis, 1  127  20  70  0  53  2  358  60  8  2  2  251  44  40  1  36  1   a   424  0  10  2  3  92  9  50  1  2  0  460  38  13  1  4  328  40  40  0  74  2  335  100  0  2  5  400  52  49  1  30  1  122  63  28  2  6  1181  100  0  0  7  0  479  0  7  3  7  485  63  38  0  77  2  590  63 although the development of de novo IgA glomerulonephritis in patients during remission from WG has been seen w30x. Both patients described in this study had circulating IgG antibodies to proteinase 3 by ELISA and c-ANCA by indirect immunohistochemistry, making the diagnosis of ANCA-associated crescentic glomerulonephritis superimposed on IgA nephropathy very likely. The fact that the mesangial hypercellularity was very mild in both cases speaks against a diagnosis of crescentic IgA nephritis w31x.
The distinction between these two clinical entities is important, as correct and prompt treatment of ANCAassociated glomerulonephritis is crucial for the prognosis of the disease, but there is no clearly indicated treatment of crescentic IgA nephritis w32x.
Using a univariate analysis we have found a positive correlation between serum creatinine and the fraction of active glomerular lesions (crescents, necrosis) and a negative correlation between serum creatinine and the fraction of normal glomeruli. These relationships were best described in a non-linear regression model (exponential). A recently published study also found the percentage of normal glomeruli to correlate to renal outcome, but did not ®nd active glomerular lesion to be signi®cantly correlated to the severity of the renal disease w25x. Only 88 of their 154 patients represented WG, the others being microscopic polyangiitis (MPA), idiopathic rapidly progressive glomerulonephritis (iRPGN), and Churg±Strauss syndrome. Renal biopsies in WG may be characterized by active lesions compared to MPA and iRPGN, where chronicity is more predominant w33x. This could indicate that different morphological features correlate to renal function in WG compared to the other clinical entities. As expected, renal function in the acute phase of the disease was also in¯uenced by the presence of interstitial nephritis and acute tubular damage. On a multiple regression analysis, however, only the percentage of normal glomeruli had a signi®cant in¯uence on serum creatinine. The relationship between serum creatinine and glomerular ®ltration rate (GFR) is described mathematically by a hyperbola, where the steepest rise in serum creatinine comes with GFR -50 mlumin w34x. In the higher ranges of glomerular renal function a decrease GFR is not necessarily followed by a signi®cant increment of serum creatinine. We propose that a study using a more precise estimate of GFR than serum creatinine could shed more light on the relationship between morphology and renal function.
There was a relatively short time span from the ®rst symptoms related to WG and renal biopsy in our patients. Signs of chronicity expressed in terms of nephron loss (tubular atrophy, glomerular sclerosis, and interstitial ®brosis) were therefore rather uncommon in the biopsies and this could be the reason for the lack of prognostic impact of these indices. There was, however, a striking increase in these features in 13 of the 14 repeat biopsies after a mean follow-up of 3.5 years. All of the 14 patients were treated with corticosteroids and immunosuppressant drugs, but this obviously did not stop the development of chronic renal failure in the majority of the patients, seven of whom had one or more relapse and one had a smouldering disease. Furthermore, the follow-up biopsies revealed that eight of the cases still had active glomerular disease and seven had crescentic glomerulonephritis ()50% crescents in the biopsies).
This study displays the wide range of morphological changes seen in renal biopsies from patients with WG. It also points to the fact that even in the absence of obvious clinical renal impairment, renal biopsy may reveal glomerular necrosis and extensive extracapillary proliferation. We have found the percentage of glomeruli with cellular crescents and the percentage of glomeruli with necrosis to correlate signi®cantly with serum creatinine, but the strongest predictor of renal function and of renal prognosis was the fraction of uninjured glomeruli. The correlation is weak, however, and although an early renal biopsy gives valuable information about the degree of renal involvement in WG, it does not seem to be of substantial help in predicting the course of renal function in the individual patient. A follow-up biopsy can be useful in revealing the degree of activity and nephron loss and may be of importance for the choice of further therapy.
